Germany: BioNTech shutting down COVID vaccine production entirely, 1,860 jobs at risk
The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to partner Pfizer. BioNTech is restructuring to focus on research and illnesses like cancer.
Source
DW News
Opens original article in a new tab